Concepedia
1
Publications
21
Citations
H-Index
2025
Active since
Affiliations
Hôpital Nord(Current)
H. Horinouchi is an author at Hôpital Nord.
Publications per year
2025–2025
Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib
H. Horinouchi, B.C. Cho, D.R. Camidge et al. · Annals of Oncology · 2025 · 21 citations · Full text
Rows per page
1–1 of 1